79 related articles for article (PubMed ID: 25182707)
1. The relationship of kinase insert domain receptor gene polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients treated with sorafenib.
Zheng YB; Zhan MX; Zhao W; Liu B; Huang JW; He X; Fu SR; Zhao Y; Li Y; Hu BS; Lu LG
Med Oncol; 2014 Oct; 31(10):209. PubMed ID: 25182707
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT Study.
Finn RS; Kudo M; Cheng AL; Wyrwicz L; Ngan RKC; Blanc JF; Baron AD; Vogel A; Ikeda M; Piscaglia F; Han KH; Qin S; Minoshima Y; Kanekiyo M; Ren M; Dairiki R; Tamai T; Dutcus CE; Ikezawa H; Funahashi Y; Evans TRJ
Clin Cancer Res; 2021 Sep; 27(17):4848-4858. PubMed ID: 34108184
[TBL] [Abstract][Full Text] [Related]
3. Association of KDR (rs2071559, rs1870377), CFH (rs1061170, rs1410996) genes variants and serum levels with pituitary adenoma.
Bruzaite A; Gedvilaite G; Kriauciuniene L; Liutkeviciene R
Mol Genet Genomic Med; 2024 Jan; 12(1):e2289. PubMed ID: 37803932
[TBL] [Abstract][Full Text] [Related]
4. Implication of KDR Polymorphism rs2071559 on Therapeutic Outcomes and Safety of Postoperative Patients with Gastric Cancer Who Received S-1-Based Adjuvant Chemotherapy: A Real-World Exploratory Study.
Meng L; Cao J; Kang L; Xu G; Yuan DW; Li K; Zhu K
Pharmgenomics Pers Med; 2023; 16():1027-1039. PubMed ID: 38046381
[TBL] [Abstract][Full Text] [Related]
5. Adverse effect of VEGFR-2 (rs1870377) polymorphism on the clinical course of COVID-19 in females and males in an age-dependent manner.
Sayın Kocakap DB; Kaygusuz S; Aksoy E; Şahin Ö; Baççıoğlu A; Ekici A; Kalpaklıoğlu AF; Ekici MS; Gül S; Kaçmaz B; Ayaşlıoğlu Açıkgöz E; Alyılmaz Bekmez S; Rouse BT; Azkur AK
Microbes Infect; 2023; 25(8):105188. PubMed ID: 37499788
[TBL] [Abstract][Full Text] [Related]
6. Kinase Insert Domain Receptor Q472H Pathogenic Germline Variant Impacts Melanoma Tumor Growth and Patient Treatment Outcomes.
Ibrahim M; Illa-Bochaca I; Fa'ak F; Monson KR; Ferguson R; Lyu C; Vega-Saenz de Miera E; Johannet P; Chou M; Mastroianni J; Darvishian F; Kirchhoff T; Zhong J; Krogsgaard M; Osman I
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201446
[TBL] [Abstract][Full Text] [Related]
7. In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer.
Rudalska R; Dauch D; Longerich T; McJunkin K; Wuestefeld T; Kang TW; Hohmeyer A; Pesic M; Leibold J; von Thun A; Schirmacher P; Zuber J; Weiss KH; Powers S; Malek NP; Eilers M; Sipos B; Lowe SW; Geffers R; Laufer S; Zender L
Nat Med; 2014 Oct; 20(10):1138-46. PubMed ID: 25216638
[TBL] [Abstract][Full Text] [Related]
8. Insights into lenvatinib resistance: mechanisms, potential biomarkers, and strategies to enhance sensitivity.
You Q; Li R; Yao J; Zhang YC; Sui X; Xiao CC; Zhang JB; Xiao JQ; Chen HT; Li H; Zhang J; Zheng J; Yang Y
Med Oncol; 2024 Feb; 41(3):75. PubMed ID: 38381181
[TBL] [Abstract][Full Text] [Related]
9. Analysis of prognostic germline polymorphisms in patients with advanced hepatocellular carcinoma.
Herman M; Lok BH; Gallinger S; Dawson L; Kim R; Cheng D; Paton T; Bucur R; Patel D; Fazelzad R; Hueniken K; Liu G
Transl Gastroenterol Hepatol; 2023; 8():32. PubMed ID: 38021355
[TBL] [Abstract][Full Text] [Related]
10. Interactions between genes altered during cardiotoxicity and neurotoxicity in zebrafish revealed using induced network modules analysis.
Agarwal M; Sharma A; Kagoo R A; Bhargava A
Sci Rep; 2023 Apr; 13(1):6257. PubMed ID: 37069190
[TBL] [Abstract][Full Text] [Related]
11. The critical role of circular RNAs in drug resistance in gastrointestinal cancers.
Samavarchi Tehrani S; Esmaeili F; Shirzad M; Goodarzi G; Yousefi T; Maniati M; Taheri-Anganeh M; Anushiravani A
Med Oncol; 2023 Mar; 40(4):116. PubMed ID: 36917431
[TBL] [Abstract][Full Text] [Related]
12. Resistance to Antiangiogenic Therapy in Hepatocellular Carcinoma: From Molecular Mechanisms to Clinical Impact.
Federico P; Giunta EF; Tufo A; Tovoli F; Petrillo A; Daniele B
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551730
[TBL] [Abstract][Full Text] [Related]
13. Genetic Polymorphisms in VEGFR Coding Genes (
Blánquez-Martínez D; Díaz-Villamarín X; García-Rodríguez S; Antúnez-Rodríguez A; Pozo-Agundo A; Martínez-González LJ; Muñoz-Ávila JI; Dávila-Fajardo CL
Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 35893809
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics of hepatocellular carcinoma and cholangiocarcinoma.
Alonso-Peña M; Sanchez-Martin A; Sanchon-Sanchez P; Soto-Muñiz M; Espinosa-Escudero R; Marin JJG
Cancer Drug Resist; 2019; 2(3):680-709. PubMed ID: 35582588
[TBL] [Abstract][Full Text] [Related]
15. Genetic Heterogeneity, Therapeutic Hurdle Confronting Sorafenib and Immune Checkpoint Inhibitors in Hepatocellular Carcinoma.
Atwa SM; Odenthal M; El Tayebi HM
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503153
[TBL] [Abstract][Full Text] [Related]
16. Molecular Bases of Drug Resistance in Hepatocellular Carcinoma.
Marin JJG; Macias RIR; Monte MJ; Romero MR; Asensio M; Sanchez-Martin A; Cives-Losada C; Temprano AG; Espinosa-Escudero R; Reviejo M; Bohorquez LH; Briz O
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32585893
[TBL] [Abstract][Full Text] [Related]
17. Role of Genetic Variations in the Hepatic Handling of Drugs.
Marin JJG; Serrano MA; Monte MJ; Sanchez-Martin A; Temprano AG; Briz O; Romero MR
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326111
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma.
De Mattia E; Cecchin E; Guardascione M; Foltran L; Di Raimo T; Angelini F; D'Andrea M; Toffoli G
World J Gastroenterol; 2019 Aug; 25(29):3870-3896. PubMed ID: 31413525
[TBL] [Abstract][Full Text] [Related]
19. Association of the rs2071559 (T/C) polymorphism with lymphatic metastasis in patients with nasopharyngeal carcinoma.
Hu K; Xie X; Wang R; Wu F; Zhang Y
Oncol Lett; 2017 Dec; 14(6):7681-7686. PubMed ID: 29344214
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
